agilon health inc. (AGL) vs Cryo-Cell International (CCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
agilon health inc. (AGL) has outperformed Cryo-Cell International (CCEL) over the past year, gaining 481.3% versus a gain of 1.5%. Over five years, CCEL leads with a -66.3% price change compared with -83.3% for AGL. agilon health inc. is the larger company by market cap ($1.52 billion vs $33.5 million), about 45.3 times the size, while Cryo-Cell International is growing revenue faster (-1.3% vs -2.1%).
On valuation, agilon health inc. trades at a lower forward P/E (20.7x vs 207.5x for Cryo-Cell International). agilon health inc. converts more of its revenue into profit, with a net margin of -6.6% versus -7.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGL | CCEL |
|---|---|---|
| Share price | $90.24 | $4.15 |
| Market cap | $1.52B | $33.46M |
| 1-day change | +0.83% | 0.00% |
| YTD return | +423.89% | +20.64% |
| 1-year return | +481.26% | +1.47% |
| 5-year return | -83.28% | -66.34% |
| Forward P/E | 20.70 | 207.50 |
| EPS (TTM) | $-6.69 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.93B | $31.57M |
| Revenue growth (YoY) | -2.11% | -1.31% |
| Net income (latest FY) | $-391.35M | $-2.43M |
| Gross margin | — | 76.63% |
| Operating margin | -7.81% | 1.53% |
| Net margin | -6.60% | -7.70% |
| 52-week high | $133.04 | $5.45 |
| 52-week low | $7.48 | $2.72 |
| Distance from 52-week high | -32.17% | -23.85% |
| Analyst consensus | buy | — |
| Avg. price target upside | +38.33% | — |
| Average volume | 226.26K | 13.02K |
| Shares outstanding | 16.80M | 8.06M |
| Employees | 856 | 72 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- agilon health inc. is about 45.3 times larger than Cryo-Cell International by market value ($1.52B vs $33.46M).
- AGL has outperformed CCEL by 479.8 percentage points over the past year.
About agilon health inc.
AGL stock →agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.
Health Care · Misc Health and Biotechnology Services · 856 employees
About Cryo-Cell International
CCEL stock →Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
Health Care · Misc Health and Biotechnology Services · 72 employees
AGL vs CCEL FAQ
Which is bigger, agilon health inc. or Cryo-Cell International?
agilon health inc. (AGL) is larger, with a market capitalization of $1.52B compared with $33.46M for Cryo-Cell International (CCEL).
Which stock has performed better over the past year, AGL or CCEL?
AGL returned +481.26% over the past 12 months, compared with +1.47% for CCEL (price return, excluding dividends). Past performance does not predict future results.
Are agilon health inc. and Cryo-Cell International in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.